Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
59.35
+0.89 (1.53%)
At close: Sep 8, 2026, 4:00 PM EDT
59.43
+0.98 (1.68%)
After-hours: Sep 8, 2026, 7:47 PM EDT
Eton Pharmaceuticals Market Cap
Eton Pharmaceuticals has a market cap or net worth of $1.7 billion as of September 8, 2026. Its market cap has increased by 257.96% in one year.
Market Cap
1.70B
Enterprise Value
1.70B
1-Year Change
257.96%
Ranking
Category
Stock Price
$59.35
ChartMarket Cap Chart
Since November 13, 2018, Eton Pharmaceuticals's market cap has increased from $105.74M to $1.70B, an increase of 1,504.19%. That is a compound annual growth rate of 42.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.70B | 274.05% |
| Dec 31, 2025 | 453.48M | 27.82% |
| Dec 31, 2024 | 354.78M | 215.68% |
| Dec 29, 2023 | 112.38M | 57.54% |
| Dec 30, 2022 | 71.34M | -32.42% |
| Dec 31, 2021 | 105.56M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bausch Health Companies | 2.40B |
| HUTCHMED (China) | 2.40B |
| Trulieve Cannabis | 2.39B |
| Prestige Consumer Healthcare | 2.36B |
| BioCryst Pharmaceuticals | 2.32B |
| Perrigo Company | 2.02B |
| Alvotech | 1.85B |
| Xeris Biopharma Holdings | 1.55B |